389 related articles for article (PubMed ID: 27530310)
1. A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients.
Alipour-Faz A; Shojaei M; Peyvandi H; Ramzi D; Oroei M; Ghadiri F; Peyvandi M
Acta Neurol Belg; 2017 Mar; 117(1):245-249. PubMed ID: 27530310
[TBL] [Abstract][Full Text] [Related]
2. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM
Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838
[TBL] [Abstract][Full Text] [Related]
3. Cost-minimization analysis comparing intravenous immunoglobulin with plasma exchange in the management of patients with myasthenia gravis.
Furlan JC; Barth D; Barnett C; Bril V
Muscle Nerve; 2016 Jun; 53(6):872-6. PubMed ID: 26521889
[TBL] [Abstract][Full Text] [Related]
4. IVIG and PLEX in the treatment of myasthenia gravis.
Bril V; Barnett-Tapia C; Barth D; Katzberg HD
Ann N Y Acad Sci; 2012 Dec; 1275():1-6. PubMed ID: 23278570
[TBL] [Abstract][Full Text] [Related]
5. Comparison of IVIg and PLEX in patients with myasthenia gravis.
Barth D; Nabavi Nouri M; Ng E; Nwe P; Bril V
Neurology; 2011 Jun; 76(23):2017-23. PubMed ID: 21562253
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
Jensen P; Bril V
J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin for myasthenia gravis.
Gajdos P; Chevret S; Toyka K
Cochrane Database Syst Rev; 2008 Jan; (1):CD002277. PubMed ID: 18254004
[TBL] [Abstract][Full Text] [Related]
8. Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis.
Liew WK; Powell CA; Sloan SR; Shamberger RC; Weldon CB; Darras BT; Kang PB
JAMA Neurol; 2014 May; 71(5):575-80. PubMed ID: 24590389
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin for myasthenia gravis.
Gajdos P; Chevret S; Toyka KV
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD002277. PubMed ID: 23235588
[TBL] [Abstract][Full Text] [Related]
10. Safety of plasma exchange therapy in patients with myasthenia gravis.
Ebadi H; Barth D; Bril V
Muscle Nerve; 2013 Apr; 47(4):510-4. PubMed ID: 23322564
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin in the preparation of thymectomy for myasthenia gravis.
Huang CS; Hsu HS; Kao KP; Huang MH; Huang BS
Acta Neurol Scand; 2003 Aug; 108(2):136-8. PubMed ID: 12859292
[TBL] [Abstract][Full Text] [Related]
12. Changes in quality of life scores with intravenous immunoglobulin or plasmapheresis in patients with myasthenia gravis.
Barnett C; Wilson G; Barth D; Katzberg HD; Bril V
J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):94-7. PubMed ID: 23154126
[TBL] [Abstract][Full Text] [Related]
13. Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial.
Gajdos P; Tranchant C; Clair B; Bolgert F; Eymard B; Stojkovic T; Attarian S; Chevret S;
Arch Neurol; 2005 Nov; 62(11):1689-93. PubMed ID: 16286541
[TBL] [Abstract][Full Text] [Related]
14. Prethymectomy plasmapheresis in myasthenia gravis.
Yeh JH; Chen WH; Huang KM; Chiu HC
J Clin Apher; 2005 Dec; 20(4):217-21. PubMed ID: 16035101
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis.
Gamez J; Salvadó M; Carmona F; de Nadal M; Romero L; Ruiz D; Jáuregui A; Martínez O; Pérez J; Suñé P; Deu M
Ther Adv Neurol Disord; 2019; 12():1756286419864497. PubMed ID: 31360225
[TBL] [Abstract][Full Text] [Related]
16. Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital.
Pittayanon R; Treeprasertsuk S; Phanthumchinda K
J Med Assoc Thai; 2009 Apr; 92(4):478-82. PubMed ID: 19374297
[TBL] [Abstract][Full Text] [Related]
17. Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study.
Heatwole C; Johnson N; Holloway R; Noyes K
J Clin Neuromuscul Dis; 2011 Dec; 13(2):85-94. PubMed ID: 22361692
[TBL] [Abstract][Full Text] [Related]
18. Treatment of myasthenia gravis acute exacerbations with intravenous immunoglobulin.
Gajdos P; Chevret S
Ann N Y Acad Sci; 2008; 1132():271-5. PubMed ID: 18096850
[TBL] [Abstract][Full Text] [Related]
19. Maintenance IVIg therapy in myasthenia gravis does not affect disease activity.
Hellmann MA; Mosberg-Galili R; Lotan I; Steiner I
J Neurol Sci; 2014 Mar; 338(1-2):39-42. PubMed ID: 24267740
[TBL] [Abstract][Full Text] [Related]
20. Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis.
Wolfe GI; Barohn RJ; Foster BM; Jackson CE; Kissel JT; Day JW; Thornton CA; Nations SP; Bryan WW; Amato AA; Freimer ML; Parry GJ;
Muscle Nerve; 2002 Oct; 26(4):549-52. PubMed ID: 12362423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]